Skip to content

Examination of SMBG patient education guidance based on Time in Range

Examination of SMBG patient education guidance based on Time in Range - Examination of SMBG patient education guidance based on Time in Range

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048202
Enrollment
60
Registered
2022-07-01
Start date
2022-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Self Monitoring of blood glucose.Blood glucose measurement 7 times a day. Medical treatment guidance.At the time of research entry, at week 8 and week 16,Conduct questionnaire surveys and diet and exe

Sponsors

Fujita Health University School of Medicine Department of Endocrinology,Diabetes and Metabolism
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who, after receiving a sufficient explanation, obtained written consent of their own free will after receiving sufficient explanations for participation in this study. 2. Patients who are 20 years of age or older at the time of obtaining consent 3. Type 2 diabetic patients who introduce SMBG through insulin treatment 4. Patients with SMBG measurement 5. Patients with exercise therapy 6. Patients with an HbA1c value of 7.0% or more but less than 10%

Exclusion criteria

Exclusion criteria: 1. Patients with an HbA1c value of less than 7.0% or more than 10% 2. Patients with neuropsychiatric disorders such as depression or alcoholism that appear to affect the evaluation of the trial 3. Patients with a malignant neoplasm 4. Patients with nephropathy stage 4 or more 5. Patients with restricted movement 6,Patients undergoing steroid therapy, anticancer drugs, interferon, or other treatments that affect blood sugar levels 7.Patients whose lead investigator or co-investigator determines that participation in the study is inappropriate from the viewpoint of the content of the study and safety.

Design outcomes

Primary

MeasureTime frame
1.Patient Satisfaction Survey 2.HbA1c Levels at Week 16 After Initiation of SMBG Coach Coaching Intervention

Secondary

MeasureTime frame
1.Correlation between SMBG's TIR and HbA1c 2.Changes in body weight (BMI), changes in muscle mass and fat mass due to inbody measurement, Blood pressure, biochemical examination

Countries

Japan

Contacts

Public ContactYusuke Seino

Fujita Health University School of Medicine Department of Endocrinology,Diabetes and Metabolism

seinoy@fujita-hu.ac.jp0562-93-9242

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026